The Molecular Glue Degradation Agent Market is experiencing rapid growth as next-generation targeted protein degradation technologies reshape therapeutic development. Valued at US$ 402 million in 2024, the market is projected to expand at a CAGR of 8.6% from 2025 to 2032. Molecular glue degradation agents, including Lysosome Targeting Chimeras (LYTACs) and Proteolytic Targeting Chimeras...